Related Experiment Video
Updated: Jul 13, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR
Sean A McKenna1, Darrin A Lindhout, Takashi Shimoike
1Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305-5126, USA.
Abstract:
Host response to viral RNA genomes and replication products represents an effective strategy to combat viral invasion. PKR is a Ser/Thr protein kinase that binds to double-stranded (ds)RNA, autophosphorylates its kinase domain, and subsequently phosphorylates eukaryotic initiation factor 2alpha (eIF2alpha). This results in attenuation of protein translation, preventing synthesis of necessary viral proteins. In certain DNA viruses, PKR function can be evaded by transcription of highly structured virus-encoded dsRNA inhibitors that bind to and inactivate PKR. We probe here the mechanism of PKR inhibition by two viral inhibitor RNAs, EBER(I) (from Epstein-Barr) and VA(I) (from human adenovirus). Native gel shift mobility assays and isothermal titration calorimetry experiments confirmed that the RNA-binding domains of PKR are sufficient and necessary for the interaction with dsRNA inhibitors. Both EBER(I) and VA(I) are effective inhibitors of PKR activation by preventing trans-autophosphorylation between two PKR molecules. The RNA inhibitors prevent self-association of PKR molecules, providing a mechanistic basis for kinase inhibition. A variety of approaches indicated that dsRNA inhibitors remain associated with PKR under activating conditions, as opposed to activator dsRNA molecules that dissociate due to reduced affinity for the phosphorylated form of PKR. Finally, we show using a HeLa cell extract system that inhibitors of PKR result in translational recovery by the protein synthesis machinery. These data indicate that inhibitory dsRNAs bind preferentially to the latent, dephosphorylated form of PKR and prevent dimerization that is required for trans-autophosphorylation.
Insights
Viral inhibitor RNAs, EBER(I) and VA(I), block protein kinase R (PKR) activation by preventing its dimerization. This mechanism inhibits viral replication by maintaining protein translation, crucial for host defense against viruses.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Host antiviral defense involves protein kinase R (PKR), a kinase activated by double-stranded RNA (dsRNA).
- PKR phosphorylates eukaryotic initiation factor 2alpha (eIF2alpha), inhibiting protein translation and viral protein synthesis.
- Viruses employ strategies to evade PKR, including using dsRNA inhibitors to inactivate PKR.
Purpose of the Study:
- To investigate the mechanism by which viral dsRNA inhibitors, EBER(I) and VA(I), inhibit PKR.
- To elucidate how these inhibitors prevent PKR activation and its downstream effects on protein translation.
Main Methods:
- Native gel shift mobility assays to study RNA-PKR interactions.
- Isothermal titration calorimetry to quantify binding affinities.
- HeLa cell extract systems to assess translational recovery.
Main Results:
- The RNA-binding domains of PKR are essential for interaction with dsRNA inhibitors.
- EBER(I) and VA(I) inhibit PKR activation by preventing trans-autophosphorylation and dimerization.
- dsRNA inhibitors remain bound to PKR, unlike activator dsRNAs that dissociate from phosphorylated PKR.
- PKR inhibitors restore protein synthesis in cell extracts.
Conclusions:
- Viral dsRNA inhibitors bind preferentially to the inactive, dephosphorylated form of PKR.
- Inhibitors block PKR dimerization, a prerequisite for kinase activation.
- This mechanism effectively counters viral strategies to evade host antiviral responses.
More Related Videos
12:43Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors Of Virion Release
Experimental RNAi